Dora Ho
Key Documents
Contact Information
-
Clinical Offices
Division of Infectious Diseases, Dept of Medicine 300 Pasteur Dr. Grant Bldg, Room S-101 Stanford, CA 94305 Tel Work (650) 736-2442 Fax (650) 723-3474
- Academic Offices
Personal Information Email Tel (650) 736-2442Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Infectious Disease
- Infectious Diseases
- Immunocompromised Host
Honors and Awards
- Postdoctoral Fellowship, Huntingtons Disease Society of America (1991-1993)
- Morris Alex, M.D. Prize for clinical medicine, Washington University School of Medicine (1999)
- Dr. Lee B. & Virginia G. Harrison Scholarship for internal medicine, Washington University School of Medicine (1999 & 2000)
- Gene transfer using herpes virus vectors as a tool for neuroprotection, US Patent No: 5661033 (1997)
Professional Education
| Board Certification: | Infectious Disease, American Board of Internal Medicine (2005) |
| Medical Education: | Washington University in St. Louis MO (2001) |
| Fellowship: | Stanford University Medical Center CA (2005) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (2004) |
| Residency: | Santa Clara Valley Medical Center, CA USA (2003) |
Graduate & Fellowship Program Affiliations
Scientific Focus
Current Research Interests
Dr. Ho did her PhD work in HSV pathogenesis and postdoctoral research in CNS gene therapy with viral vectors. Her current interests are in viral and fungal infections in immunocompromised patients and her research focuses on infection complications in neutropenic patients. In collaboration with Dr. C. Dekker of the Stanford-LPCH Vaccine Program and with Dr. J. Brown of the BMT Division, she is also conducting clinical trials on vaccines, antivirals and antifungals as a co-investigator.
Clinical Trials
- 2009 Novel H1N1 Influenza Vaccine Study No longer recruiting
- A Study of an Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults No longer recruiting
- An Observational Study of Fungal Biomarkers No longer recruiting
- Phase III of 2 Dosing Regimens of Caspofungin in the Treatment of Invasive Candidiasis in Adults Completed
- Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients Completed
Publications
- Early CMV viremia is associated with impaired viral control following nonmyeloablative hematopoietic cell transplantation with a total lymphoid irradiation and antithymocyte globulin preparative regimen. Biol Blood Marrow Transplant. 2011; (5): 693-702
- Treatment of acyclovir-resistant herpes simplex virus with continuous infusion of high-dose acyclovir in hematopoietic cell transplant patients. Biol Blood Marrow Transplant. 2011; (2): 259-64
- Yield of diagnostic procedures for invasive fungal infections in neutropenic febrile patients with chest computed tomography abnormalities. Mycoses. 2011; (1): 59-70
- Varicella Zoster Virus In: Yu VL, Weber R, Raoult D (eds.), Antinicrobial Therapy and Vaccines 3rd edition. 2009
- Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine. Vaccine. 2008; (32): 4057-61
